Carboplatin versus two doses of cisplatin in combination with gemcitabine in the treatment of advanced non-small-cell lung cancer: Results from a British Thoracic Oncology Group randomised phase III trial

Ferry, D., Billingham, L., Jarrett, H. et al. (16 more authors) (2017) Carboplatin versus two doses of cisplatin in combination with gemcitabine in the treatment of advanced non-small-cell lung cancer: Results from a British Thoracic Oncology Group randomised phase III trial. European Journal of Cancer, 83. pp. 302-312. ISSN 0959-8049

Abstract

Metadata

Authors/Creators:
  • Ferry, D.
  • Billingham, L.
  • Jarrett, H.
  • Dunlop, D.
  • Woll, P.J. https://orcid.org/0000-0002-1118-0831
  • Nicolson, M.
  • Shah, R.
  • Thompson, J.
  • Spicer, J.
  • Muthukumar, D.
  • Skailes, G.
  • Leonard, P.
  • Chetiyawardana, A.D.
  • Wells, P.
  • Lewanski, C.
  • Crosse, B.
  • Hill, M.
  • Gaunt, P.
  • O'Byrne, K.
Copyright, Publisher and Additional Information: © 2017 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/ licenses/by/4.0/).
Keywords: Non-small-cell lung cancer; Carboplatin; Cisplatin; Gemcitabine; Randomised phase III trial; Quality of life
Dates:
  • Published: 1 September 2017
  • Published (online): 4 August 2017
  • Accepted: 19 May 2017
Institution: The University of Sheffield
Depositing User: Symplectic Sheffield
Date Deposited: 19 Sep 2017 13:59
Last Modified: 19 Sep 2017 13:59
Published Version: https://doi.org/10.1016/j.ejca.2017.05.037
Status: Published
Publisher: Elsevier
Refereed: Yes
Identification Number: https://doi.org/10.1016/j.ejca.2017.05.037

Share / Export

Statistics